Diverse immune mechanisms may contribute to the survival benefit seen in cancer patients receiving hyperthermia

Immunologic Research

Volumn 46, Issue 1-3, 2010, Pages 137-154

  Peer, Adrienne J ^a   Grimm, Melissa J ^a   Zynda, Evan R ^a   Repasky, Elizabeth A ^a,b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

Dendritic cells; Hyperthermia; Immune response; Neutrophils; NK cells Macrophages; T cells; Thermal stress

Indexed keywords

CYTOKINE; HEAT SHOCK PROTEIN; HEAT SHOCK TRANSCRIPTION FACTOR 1;

CANCER PATIENT; CANCER SURVIVAL; CELL FUNCTION; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CORE TEMPERATURE; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; HUMAN; HYPERTHERMIC THERAPY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; LANGERHANS CELL; NATURAL KILLER CELL; NONHUMAN; PERITONEUM MACROPHAGE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SPLEEN CELL; TEMPERATURE SENSITIVITY; TEMPERATURE STRESS; THERMOREGULATION; TUMOR IMMUNITY;

ANIMALS; HUMANS; HYPERTHERMIA, INDUCED; IMMUNE SYSTEM; NEOPLASMS; SURVIVAL ANALYSIS; TEMPERATURE;

EID: 77949401920     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-009-8115-8     Document Type: Review

References (93)

1. Valdagni R, Amichetti M. Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys. 1994;28(1):163-9.
2. Overgaard J, et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European society for hyperthermic oncology. Lancet. 1995;345(8949):540-3.
3. Sugimachi K, et al. Hyperthermia combined with chemotherapy and irradiation for patients with carcinoma of the oesophagus-a prospective randomized trial. Int J Hyperthermia. 1992;8(3):289-95.
4. Sugimachi K, et al. Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: a prospective randomized trial. Int J Hyperthermia. 1994;10(4):485-93.
5. van der Zee J, et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet. 2000;355(9210):1119- 25.
6. Sneed PK, et al. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 1998;40(2):287-95.
7. Vernon CC, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys. 1996;35(4):731-44.
8. Jones EL, et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol. 2005;23(13):3079-85.
9. Corry PM, Armour EP. The heat shock response: role in radiation biology and cancer therapy. Int J Hyperthermia. 2005;21(8):769-78.
10. Iliakis G, Wu W, Wang M. DNA double strand break repair inhibition as a cause of heat radiosensitization: re-evaluation considering backup pathways of NHEJ. Int J Hyperthermia. 2008;24(1):17-29.
11. Xu Y, et al. Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin. Int J Hyperthermia. 2007;23(6):513-27.
12. Souslova T, Averill-Bates DA. Multidrug-resistant hela cells overexpressing MRP1 exhibit sensitivity to cell killing by hyperthermia: interactions with etoposide. Int J Radiat Oncol Biol Phys. 2004;60(5):1538-51.
13. Di YP, et al. Hsp70 translocates into a cytoplasmic aggregate during lymphocyte activation. J Cell Physiol. 1995;165(2):228-38.
14. Di YP, Repasky EA, Subjeck JR. Distribution of HSP70, protein kinase C, and spectrin is altered in lymphocytes during a fever-like hyperthermia exposure. J Cell Physiol. 1997;172(1):44-54.
15. Burd R, et al. Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia. J Cell Physiol. 1998;177(1):137-47.
16. Wang WC, et al. Fever-range hyperthermia enhances L-selectin-dependent adhesion of lymphocytes to vascular endothelium. J Immunol. 1998;160(2):961-9.
17. Ostberg JR, et al. Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells. J Leukoc Biol. 2007;82(5):1322-31.
18. Hasday JD, Fairchild KD, Shanholtz C. The role of fever in the infected host. Microbes Infect. 2000;2(15):1891-904.
19. Mackowiak PA, et al. Concepts of fever: recent advances and lingering dogma. Clin Infect Dis. 1997;25(1):119-38.
20. Kluger MJ, Ringler DH, Anver MR. Fever and survival. Science. 1975;188(4184):166-8.
21. Commission IT. Glossary of terms of thermal physiology. Third Edition. Jpn J Physiol. 2001;51:245-80.
22. Gordon C. Temperature regulation in the laboratory rodent. New York: Cambridge University Press; 1993.
23. Jiang Q, et al. Febrile core temperature is essential for optimal host defense in bacterial peritonitis. Infect Immun. 2000;68(3):1265-70.
24. Wiemann B, Starnes CO. Coley's toxins, tumor necrosis factor and cancer research: a historical perspective. Pharmacol Ther. 1994;64(3):529-64.
25. Nauts HC, McLaren JR. Coley toxins-the first century. Adv Exp Med Biol. 1990;267:483-500.
26. Sakamoto J, Satoshi T, Watanabe Y, Hayata Y, Okayasu T, Nakazato H, et al. Meta-analysis of adjuvant immunochemotherapy using OK-432 in patients with resected non-small-cell lung cancer. J Immunother. 2001;24(3):250-6.
27. Hobohm U. Fever and cancer in perspective. Cancer Immunol Immunother. 2001;50(8):391-6.
28. Brizel DM, et al. Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Res. 1996;56(23):5347-50.
29. Kappel M, et al. Effects of in vitro hyperthermia on the proliferative response of blood mononuclear cell subsets, and detection of interleukins 1 and 6, tumour necrosis factor-alpha and interferon-gamma. Immunology. 1991;73(3):304-8.
30. Ozawa H, Matsuda T, Iwaguchi T. Whole-body hyperthermia maintains the secondary immune response of specific antitumour immune T cells. Int J Hyperthermia. 1991;7(1):125-30.
31. Ostberg JR, et al. Regulatory potential of fever-range whole body hyperthermia on Langerhans cells and lymphocytes in an antigen-dependent cellular immune response. J Immunol. 2001;167(5):2666-70.
32. Evans SS, et al. Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venules. Blood. 2001;97(9):2727-33.
33. Hatzfeld-Charbonnier AS, et al. Influence of heat stress on human monocyte-derived dendritic cell functions with immunotherapeutic potential for antitumor vaccines. J Leukoc Biol. 2007;81(5):1179-87.
34. Harris JW, Meneses JJ. Effects of hyperthermia on the production and activity of primary and secondary cytolytic T-lymphocytes in vitro. Cancer Res. 1978;38(4):1120-6.
35. Roberts NJ Jr, Sandberg K. Hyperthermia and human leukocyte function: II. Enhanced production of and response to leukocyte migration inhibition factor (LIF). J Immunol. 1993;122:1990-3.
36. Koga S, et al. The effects of total-body hyperthermia combined with anticancer drugs on immunity in advanced cancer patients. Cancer. 1983;52(7):1173-7.
37. Shen RN, et al. Influence of elevated temperature on natural killer cell activity, lymphokine-activated killer cell activity and lectin-dependent cytotoxicity of human umbilical cord blood and adult blood cells. Int J Radiat Oncol Biol Phys. 1994;29(4):821-6.
38. Choi M, et al. Short-term heat exposure inhibits inflammation by abrogating recruitment of and nuclear factor-{kappa}B activation in neutrophils exposed to chemotactic cytokines. Am J Pathol. 2008;172:367-777.
39. Rice P, et al. Febrile-range hyperthermia augments neutrophil accumulation and enhances lung injury in experimental gram-negative bacterial pneumonia. J Immunol. 2005;174(6):3676-85.
40. Grabbe S, Schwarz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today. 1998;19(1):37-44.
41. Ostberg JR, Patel R, Repasky EA. Regulation of immune activity by mild (fever-range) whole body hyperthermia: effects on epidermal Langerhans cells. Cell Stress Chaper. 2000;5(5):458-61.
42. Ostberg JR, Kabingu E, Repasky EA. Thermal regulation of dendritic cell activation and migration from skin explants. Int J Hyperthermia. 2003;19(5):520-33.
43. Peng JC, et al. Monocyte-derived DC primed with TLR agonists secrete IL-12p70 in a CD40-dependent manner under hyperthermic conditions. J Immunother. 2006;29(6):606-15.
44. Tournier JN, et al. Fever-like thermal conditions regulate the activation of maturing dendritic cells. J Leukoc Biol. 2003;73(4):493-501.
45. Evans SS, et al. Dynamic association of L-selectin with the lymphocyte cytoskeletal matrix. J Immunol. 1999;162(6):3615-24.
46. Rescigno M, Granucci F, Ricciardi-Castagnoli P. Molecular events of bacterial-induced maturation of dendritic cells. J Clin Immunol. 2000;20(3):161-6.
47. Ensor JE, et al. Differential effects of hyperthermia on macrophage interleukin-6 and tumor necrosis factor-alpha expression. Am J Physiol. 1994;96(4 Pt 1):C967-74.
48. Ensor JE, Crawford EK, Hasday JD. Warming macrophages to febrile range destabilizes tumor necrosis factor-alpha mRNA without inducing heat shock. Am J Physiol. 1995;269(5 Pt 1):C1140-6.
49. Moser M, Murphy KM. Dendritic cell regulation of TH1-TH2 development. Nat Immunol. 2000;1(3):199-205.
50. Ostberg JR, et al. Regulatory effects of fever-range whole-body hyperthermia on the LPS-induced acute inflammatory response. J Leukoc Biol. 2000;68(6):815-20.
51. Jiang Q, et al. Exposure to febrile temperature upregulates expression of pyrogenic cytokines in endotoxin-challenged mice. Am J Physiol. 1999;276(6 Pt 2):R1653-60.
52. Jiang Q, et al. Febrile-range temperature modifies early systemic tumor necrosis factor alpha expression in mice challenged with bacterial endotoxin. Infect Immun. 1999;67(4):1539-46.
53. Rosenspire AJ, Kindzelskii AL, Petty HR. Cutting edge: fever-associated temperatures enhance neutrophil responses to lipopolysaccharide: a potential mechanism involving cell metabolism. J Immunol. 2002;169(10):5396-400.
54. Pritchard MT, Li Z, Repasky EA. Nitric oxide production is regulated by fever-range thermal stimulation of murine macrophages. J Leukoc Biol. 2005;78(3):630-8.
55. Smith JB, Knowlton RP, Agarwal SS. Human lymphocyte responses are enhanced by culture at 40 degrees C. J Immunol. 1978;121(2):691-4.
56. Roberts NJ Jr, Steigbigel RT. Effect of in vitro virus infection on response of human monocytes and lymphocytes to mitogen stimulation. J Immunol. 1978;121(3):1052-8.
57. Manzella JP, Roberts NJ Jr. Human macrophage and lymphocyte responses to mitogen stimulation after exposure to influenza virus, ascorbic acid, and hyperthermia. J Immunol. 1979;123(5):1940-4.
58. Jampel HD, et al. Fever and immunoregulation. III. Hyperthermia augments the primary in vitro humoral immune response. J Exp Med. 1983;157(4):1229-38.
59. Ciavarra RP, Silvester S, Brody T. Analysis of T-cell subset proliferation at afebrile and febrile temperatures: differential response of Lyt-1?23- lymphocytes to hyperthermia following mitogen and antigen stimulation and its functional consequence on development of cytotoxic lymphocytes. Cell Immunol. 1987;107(2):293-306.
60. Duff GW. Interleukin-1 and fever. Rheumatology. 1985;XXIV(Suppl 1):12-4.
61. Oglesbee MJ, et al. Whole body hyperthermia: effects upon canine immune and hemostatic functions. Vet Immunol Immunopathol. 1999;69(2-4):185-99.
62. Hanson DF. Fever and the immune response. The effects of physiological temperatures on primary murine splenic T-cell responses in vitro. J Immunol. 1993;151(1):436-48.
63. Cippitelli M, et al. Hyperthermia enhances CD95-ligand gene expression in T lymphocytes. J Immunol. 2005;174(1):223-32.
64. Yoshioka H, et al. The influence of hyperthermia in vitro on the functions of peritoneal macrophages in mice. Jpn J Surg. 1990;20(1):119-22.
65. Morimoto RI. Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev. 1998;12(24):3788-96.
66. Tanabe M, et al. Different thresholds in the responses of two heat shock transcription factors, HSF1 and HSF3. J Biol Chem. 1997;272(24):15389-95.
67. Singh IS, et al. Inhibition of tumor necrosis factor-alpha transcription in macrophages exposed to febrile range temperature. A possible role for heat shock factor-1 as a negative transcriptional regulator. J Biol Chem. 2000;275(13):9841-8.
68. Nagarsekar A, Hasday JD, Singh IS. CXC chemokines: a new family of heat-shock proteins? Immunol Invest. 2005;34(3):381-98.
69. Lancaster GI, Febbraio MA. Exosome-dependent trafficking of HSP70: a novel secretory pathway for cellular stress proteins. J Biol Chem. 2005;280(24):23349-55.
70. Pockley AG. Heat shock proteins as regulators of the immune response. Lancet. 2003;362(9382):469-76.
71. Ostberg JR, Kaplan KC, Repasky EA. Induction of stress proteins in a panel of mouse tissues by fever-range whole body hyperthermia. Int J Hyperthermia. 2002;18(6):552-62.
72. Wang XY, Ostberg JR, Repasky EA. Effect of fever-like whole-body hyperthermia on lymphocyte spectrin distribution, protein kinase C activity, and uropod formation. J Immunol. 1999;162(6):3378-87.
73. Cella M, et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med. 1996;184:747-52.
74. Becker T, Hartl FU, Wieland F. CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J Cell Biol. 2002;158:1277-85.
75. Dykstra M, et al. Location is everything: lipid rafts and immune cell signaling. Annu Rev Immunol. 2003;21:457-81.
76. Simons K, Ikonen E. Functional rafts in cell membranes. Nature. 1997;387(6633):569-72.
77. Brown DA, London E. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol. 1998;14:111-36.
78. Pralle A, et al. Three-dimensional high-resolution particle tracking for optical tweezers by forward scattered light. Microsc Res Tech. 1999;44(5):378-86.
79. Chen Q, et al. Central role of IL-6 receptor signal-transducing chain gp130 in activation of L-selectin adhesion by fever-range thermal stress. Immunity. 2004;20(1):59-70.
80. Ndubuisi MI, et al. Distinct classes of chaperoned IL-6 in human blood: differential immunological and biological availability. J Immunol. 1998;160(1):494-501.
81. Sehgal PB. Interleukin-6-type cytokines in vivo: regulated bioavailability. Proc Soc Exp Biol Med. 1996;213(3):238-47.
82. Chen Q, et al. Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism. Nat Immunol. 2006;7(12):1299-308.
83. Payne J, et al. Mild hyperthermia modulates biological activities of interferons. Int J Hyperthermia. 2000;16(6):492-507.
84. Fleischmann WR Jr, Fleischmann CM, Gindhart TD. Effect of hyperthermia on combination interferon treatment: enhancement of the antiproliferative activity against murine B-16 melanoma. Cancer Res. 1986;46(4 Pt 1):1722-6.
85. Groveman DS, et al. Augmented antiproliferative effects of interferons at elevated temperatures against human bladder carcinoma cell lines. Cancer Res. 1984;44(12 Pt 1):5517-21.
86. Williams BRG, Kerr IM. Inhibition of protein synthesis by 2[prime]-5[prime] linked adenine oligonucleotides in intact cells. Nature. 1978;276(5683):88-90.
87. Chang CC, Wu JM. Modulation of antiviral activity of interferon and 20,50-oligoadenylate synthetase gene expression by mild hyperthermia (39.5 degrees C) in cultured human cells. J Biol Chem. 1991;266(7):4605-12.
88. Orlando A, et al. Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials. Am J Gastroenterol. 2009;104(2):514-24.
89. Timmerman RD, et al. Local surgical, ablative, and radiation treatment of metastases. CA Cancer J Clin. 2009;59(3):145-70.
90. Thrall DE, et al. Changes in tumour oxygenation during fractionated hyperthermia and radiation therapy in spontaneous canine sarcomas. Int J Hyperthermia. 2006;22(5):365-73.
91. Vujaskovic Z, et al. Temperature-dependent changes in physiologic parameters of spontaneous canine soft tissue sarcomas after combined radiotherapy and hyperthermia treatment. Int J Radiat Oncol Biol Phys. 2000;46(1):179-85.
92. Song CW, Park H, Griffin RJ. Improvement of tumor oxygenation by mild hyperthermia. Radiat Res. 2001;155(4):515-28.
93. Dewhirst MW, et al. Re-setting the biological rationale for thermal therapy. Int J Hyperthermia. 2005;21:779-90.